Published on in Vol 5, No 4 (2019): Oct-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/12016, first published
.

Human Vaccines & Immunotherapeutics
Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives |
Drug Safety
Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season |
Advances in Therapy
Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis |